the protocol utilizes infusions of autologous mononuclear leukocytes treated with the oxidizing mitogen sodium periodate ( io4- ) and cultured in medium containing human recombinant interleukin-2 ( il-2 ) , and continuous infusions of low-dose il-2 ( mean +/- sd dose = 39.5 +/- 8.6 x 10 ( 3 ) u/kg/24 hours ) .
C0086418
human
C0021756
il-2